BSX
$97.72
Revenue | $5065Mn |
Net Profits | $755Mn |
Net Profit Margins | 14.91% |
Boston Scientific Corp.’s revenue jumped 20.34% since last year same period to $5065Mn in the Q3 2025. On a quarterly growth basis, Boston Scientific Corp. has generated 0.08% jump in its revenue since last 3-months.
Boston Scientific Corp.’s net profit jumped 60.98% since last year same period to $755Mn in the Q3 2025. On a quarterly growth basis, Boston Scientific Corp. has generated -4.79% fall in its net profits since last 3-months.
Boston Scientific Corp.’s net profit margin jumped 33.77% since last year same period to 14.91% in the Q3 2025. On a quarterly growth basis, Boston Scientific Corp. has generated -4.87% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.71 |
EPS Estimate Current Year | 0.71 |
Boston Scientific Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.71 - a -2.74% fall from last quarter’s estimates.
Boston Scientific Corp.’s earning per share (EPS) estimates for the current year stand at 0.71.
Earning Per Share (EPS) | 0 |
Boston Scientific Corp.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Boston Scientific Corp. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-09-30 | 0.71 | 0 | -100% |
2025-08-01 | 0.73 | 0.75 | 2.74% |
2025-05-01 | 0.67 | 0.75 | 11.94% |